Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Parkin, P. Pisani, J. Ferlay (1999)
Estimates of the worldwide incidence of 25 major cancers in 1990International Journal of Cancer, 80
A. Kekulé, U. Lauer, L. Weiss, B. Luber, P. Hofschneider (1993)
Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathwayNature, 361
I. Hsu, R. Metcalf, T. Sun, J. Welsh, N. Wang, C. Harris (1991)
Mutational hotspot in the p53 gene in human hepatocellular carcinomas.Nature, 350 6317
P. Keskinen, K. Melén, I. Julkunen (2002)
Expression of HCV structural proteins impairs IFN-mediated antiviral response.Virology, 299 2
A. Zhu (2003)
Hepatocellular Carcinoma: Are We Making Progress?Cancer Investigation, 21
K. Lan, M. Sheu, Shinn-Jang Hwang, S. Yen, Shiow-Yi Chen, Jaw‐Ching Wu, Yuan‐Jan Wang, N. Kato, M. Omata, F. Chang, Shou-Dong Lee (2002)
HCV NS5A interacts with p53 and inhibits p53-mediated apoptosisOncogene, 21
G. Reyes (2002)
The nonstructural NS5A protein of hepatitis C virus: an expanding, multifunctional role in enhancing hepatitis C virus pathogenesis.Journal of biomedical science, 9 3
Mounia Chami, D. Gozuacik, K. Saigo, T. Capiod, P. Falson, H. Lecoeur, T. Urashima, Jack Beckmann, M. Gougeon, M. Claret, M. Maire, C. Bréchot, P. Paterlini-Bréchot (2000)
Hepatitis B virus-related insertional mutagenesis implicates SERCA1 gene in the control of apoptosisOncogene, 19
Yong Lin, T. Nomura, J. Cheong, D. Dorjsuren, K. Iida, S. Murakami (1997)
Hepatitis B Virus X Protein Is a Transcriptional Modulator That Communicates with Transcription Factor IIB and the RNA Polymerase II Subunit 5*The Journal of Biological Chemistry, 272
K. Yaginuma, Y. Shirakata, M. Kobayashi, K. Koike (1987)
Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.Proceedings of the National Academy of Sciences of the United States of America, 84 9
J. Bénard, S. Douc-Rasy, J. Ahomadegbe (2003)
TP53 family members and human cancersHuman Mutation, 21
S. Brillanti, M. Foli, S. Gaiani, C. Masci, M. Miglioli, Luigi Barbara (1993)
Persistent hepatitis C viraemia without liver diseaseThe Lancet, 341
R. Truant, Jovan Antunovic, J. Greenblatt, C. Prives, J. Cromlish (1995)
Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivationJournal of Virology, 69
El‐Serag El‐Serag, Mason Mason (1999)
Rising incidence of hepatocellular carcinoma in the United StatesN Engl J Med, 340
Jin Kwon, H. Rho (2003)
Transcriptional Repression of the Human p53 Gene by Hepatitis B Viral Core Protein (HBc) in Human Liver Cells, 384
P. Chirillo, S. Pagano, G. Natoli, P. Puri, V. Burgio, C. Balsano, M. Levrero (1997)
The hepatitis B virus X gene induces p53-mediated programmed cell death.Proceedings of the National Academy of Sciences of the United States of America, 94 15
T. De-Medina, I. Haviv, S. Noiman, Y. Shaul (1994)
The X protein of hepatitis B virus has a ribo/deoxy ATPase activity.Virology, 202 1
D. Woodfield (1986)
Hepatocellular carcinoma.The New Zealand medical journal, 99 795
D. Moradpour, H. Blum (2005)
Pathogenesis of hepatocellular carcinoma.European journal of gastroenterology & hepatology, 17 5
Takayuki Yamanaka, T. Kodama, T. Doi (2002)
Subcellular localization of HCV core protein regulates its ability for p53 activation and p21 suppression.Biochemical and biophysical research communications, 294 3
M. Wollersheim, U. Debelka, P. Hofschneider (1988)
A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state.Oncogene, 3 5
J. Pugh, M. Bassendine (1990)
Molecular biology of hepadnavirus replication.British medical bulletin, 46 2
W. Ryu (2003)
Molecular aspects of hepatitis B viral infection and the viral carcinogenesis.Journal of biochemistry and molecular biology, 36 1
X. Wang (2000)
Abrogation of p53-Induced Apoptosis by the Hepatitis B Virus X Gene.Methods in molecular medicine, 45
K. Khabar, S. Polyak (2002)
Hepatitis C virus-host interactions: the NS5A protein and the interferon/chemokine systems.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 22 10
Ikeda Ikeda, Saitoh Saitoh, Suzuki Suzuki (1998)
Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot studyCancer, 82
A. Bisceglie, Z. Goodman, K. Ishak, J. Hoofnagle, Jacqueline Melpolder, H. Alter (1991)
Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitisHepatology, 14
R. Romeo, M. Colombo (2002)
The natural history of hepatocellular carcinoma.Toxicology, 181-182
Q. Choo, G. Kuo, A. Weiner, L. Overby, D. Bradley, M. Houghton (1989)
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.Science, 244 4902
N. Arima, C. Kao, T. Licht, R. Padmanabhan, Y. Sasaguri, R. Padmanabhan (2001)
Modulation of Cell Growth by the Hepatitis C Virus Nonstructural Protein NS5A*The Journal of Biological Chemistry, 276
R. Zakut, D. Givol (1995)
The tumor suppression function of p21Waf is contained in its N-terminal half ('half-WAF').Oncogene, 11 2
H. Kwun, E. Jung, J. Ahn, M. Lee, K. Jang (2001)
p53-dependent transcriptional repression of p21(waf1) by hepatitis C virus NS3.The Journal of general virology, 82 Pt 9
I. Qadri, M. Iwahashi, F. Simon (2002)
Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3.Biochimica et biophysica acta, 1592 2
F. Su, R. Schneider (1997)
Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha.Proceedings of the National Academy of Sciences of the United States of America, 94 16
M. Bouchard, S. Giannakopoulos, E. Wang, N. Tanese, R. Schneider (2001)
Hepatitis B Virus HBx Protein Activation of Cyclin A–Cyclin-Dependent Kinase 2 Complexes and G1 Transit via a Src Kinase PathwayJournal of Virology, 75
Pascal Pineau, A. Marchio, Benoit Terris, MARIE-GENEVIÈVE Mattei, ZHEN-XING Tu, Pierre Tiollais, Anne Dejean (1996)
A t(3;8) chromosomal translocation associated with hepatitis B virus intergration involves the carboxypeptidase N locusJournal of Virology, 70
Erwin Graef, W. Caselmann, J. Wells, R. Koshy (1994)
Insertional activation of mevalonate kinase by hepatitis B virus DNA in a human hepatoma cell line.Oncogene, 9 1
Waris Waris (2003)
Regulatory mechanisms of viral hepatitis B and CJ Biosci, 28
El‐Serag El‐Serag (2001)
Epidemiology of hepatocellular carcinomaClin Liver Dis, 5
M. Otsuka, N. Kato, K. Lan, H. Yoshida, Jun‐ichi Kato, T. Goto, Y. Shiratori, M. Omata (2000)
Hepatitis C Virus Core Protein Enhances p53 Function through Augmentation of DNA Binding Affinity and Transcriptional Ability*The Journal of Biological Chemistry, 275
M. Prieto, V. Olaso, C. Verdú, J. Córdoba, C. Gisbert, M. Rayón, D. Carrasco, M. Berenguer, M. Higón, J. Berenguer (1995)
Does the healthy hepatitis C virus carrier state really exist? an analysis using polymerase chain reactionHepatology, 22
C. Giannini, C. Bréchot (2003)
Hepatitis C virus biologyCell Death and Differentiation, 10
M. Greenblatt, W. Bennett, M. Hollstein, C. Harris (1994)
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.Cancer research, 54 18
Koike Koike (2002)
Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studiesJ Gastroenterol, 37
Jian Wang, X. Chenivesse, B. Henglein, C. Bréchot (1990)
Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinomaNature, 343
R. Beasley (1988)
Hepatitis B virus. The major etiology of hepatocellular carcinomaCancer, 61
M. Feitelson, Ling-Xun, Duant (1997)
Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.The American journal of pathology, 150 4
Zoltán Oltval, C. Milliman, S. Korsmeyer (1993)
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 74
Ishtiaq Qadri, J. Conaway, R. Conaway, Jerome Schaack, Aleem Siddiqui (1996)
Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH.Proceedings of the National Academy of Sciences of the United States of America, 93 20
K. Koike, T. Tsutsumi, H. Fujie, Y. Shintani, K. Moriya (2002)
Molecular Mechanism of Viral HepatocarcinogenesisOncology, 62
Macdonald Macdonald (2001)
Pathogenesis of hepatocellular carcinomaClin Liver Dis, 5
D. Gozuacik, Y. Murakami, K. Saigo, Mounia Chami, C. Mugnier, D. Lagorce, T. Okanoue, T. Urashima, C. Bréchot, P. Paterlini-Bréchot (2001)
Identification of human cancer-related genes by naturally occurring Hepatitis B Virus DNA taggingOncogene, 20
T. Yen (1996)
Hepadnaviral X Protein:Review of Recent Progress.Journal of biomedical science, 3 1
S. Muramatsu, S. Ishido, T. Fujita, M. Itoh, H. Hotta (1997)
Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localizationJournal of Virology, 71
M. Majumder, A. Ghosh, R. Steele, R. Ray, R. Ray (2001)
Hepatitis C Virus NS5A Physically Associates with p53 and Regulates p21/waf1 Gene Expression in a p53-Dependent MannerJournal of Virology, 75
S. Ishido, Sanshiro Muramatsu, T. Fujita, Yasuhiro Iwanaga, W. Tong, Y. Katayama, M. Itoh, H. Hotta (1997)
Wild-type, but not mutant-type, p53 enhances nuclear accumulation of the NS3 protein of hepatitis C virus.Biochemical and biophysical research communications, 230 2
S. Ishido, H. Hotta (1998)
Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressorFEBS Letters, 438
K. Kinzler, B. Vogelstein (1994)
Cancer therapy meets p53.The New England journal of medicine, 331 1
M. Zhu, Y. Dai, R. Zhan (1999)
[HBxAg enhanced p53 protein accumulation in hepatoma cells].Zhonghua bing li xue za zhi = Chinese journal of pathology, 28 1
C. Bréchot, D. Gozuacik, Y. Murakami, P. Paterlini-Bréchot (2000)
Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).Seminars in cancer biology, 10 3
M. Houghton, A. Weiner, Jang Han, G. Kuo, Q. Choo (1991)
Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral diseaseHepatology, 14
M. Koffler (1965)
Epidemiology of hepatitis.Lancet, 2 7417
A. Varaklioti, N. Vassilaki, U. Georgopoulou, P. Mavromara (2002)
Alternate Translation Occurs within the Core Coding Region of the Hepatitis C Viral Genome*The Journal of Biological Chemistry, 277
Hongshuang Chen, S. Kaneko, R. Girones, Robert Anderson, Hornbuckle We, B. Tennant, P. Cote, Gerin Jl, R. Purcell, Roger Miller (1993)
The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucksJournal of Virology, 67
T. Huo, X. Wang, M. Forgues, Chuan-ging Wu, E. Spillare, C. Giannini, C. Bréchot, C. Harris (2001)
Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosisOncogene, 20
B. Bressac, M. Kew, J. Wands, M. Ozturk (1991)
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern AfricaNature, 350
James Cross, Ping Wen, William Rutter (1993)
Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases.Proceedings of the National Academy of Sciences of the United States of America, 90 17
Hussain Hussain, Ferry Ferry, El‐Gazzaz El‐Gazzaz (2001 Feb)
Hepatocellular carcinomaAnn Oncol, 12
P. Tran, J. Vigneron, D. Péricat, S. Dubois, D. Cazals, M. Hervy, Y. DeClerck, C. Degott, C. Auclair (2003)
Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3Cancer Gene Therapy, 10
P. Paterlini, C. Bréchot (1991)
The detection of hepatitis B virus (HBV) in HBsAg negative individuals with primary liver cancerDigestive Diseases and Sciences, 36
H. Kwun, K. Jang (2003)
Dual effects of hepatitis C virus Core protein on the transcription of cyclin‐dependent kinase inhibitor p21 geneJournal of Viral Hepatitis, 10
Jacqueline Benn, R. Schneider (1994)
Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade.Proceedings of the National Academy of Sciences of the United States of America, 91 22
Bill Sun, Xianhua Zhu, M. Clayton, Jingbo Pan, M. Feitelson (1998)
Identification of a protein isolated from senescent human cells that binds to hepatitis B virus X antigenHepatology, 27
H. Sirma, C. Giannini, K. Poussin, P. Paterlini, D. Kremsdorf, C. Bréchot (1999)
Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBxOncogene, 18
A. Dejean, L. Bougueleret, K. Grzeschik, P. Tiollais (1986)
Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinomaNature, 322
D. Ganem, H. Varmus (1987)
The molecular biology of the hepatitis B viruses.Annual review of biochemistry, 56
O. Hino, K. Kajino, T. Umeda, Y. Arakawa (2002)
Understanding the hypercarcinogenic state in chronic hepatitis: a clue to the prevention of human hepatocellular carcinomaJournal of Gastroenterology, 37
Craig Shapiro (1993)
Epidemiology of hepatitis B.The Pediatric infectious disease journal, 12 5
G. Dusheiko, A. Burroughs, K. Hobbs, R. Dick (1992)
Treatment of small hepatocellular carcinomasThe Lancet, 340
Tiollais Tiollais, Pourcel Pourcel, Dejean Dejean (1985)
The hepatitis B virusNature, 317
M. Colombo (1995)
Epidemiology of hepatocellular carcinoma.The Italian journal of gastroenterology, 27 2
F. Zoulim, J. Saputelli, C. Seeger (1994)
Woodchuck hepatitis virus X protein is required for viral infection in vivoJournal of Virology, 68
Mei‐Hwei Chang, Chien-Jen Chen, M. Lai, H. Hsu, Tzee-Chung Wu, M. Kong, Der-Cherng Liang, W. Shau, Ding‐Shinn Chen (1997)
Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.The New England journal of medicine, 336 26
Y. Haupt, S. Rowan, E. Shaulian, K. Vousden, M. Oren (1995)
Induction of apoptosis in HeLa cells by trans-activation-deficient p53.Genes & development, 9 17
J. Cheong, M. Yi, Yong Lin, S. Murakami (1995)
Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation.The EMBO Journal, 14
A. Alisi, S. Giambartolomei, F. Cupelli, P. Merlo, G. Fontemaggi, A. Spaziani, C. Balsano (2003)
Physical and functional interaction between HCV core protein and the different p73 isoformsOncogene, 22
Tae-Wook Chung, Young-Choon Lee, J. Ko, Cheorl-Ho Kim (2003)
Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells.Cancer research, 63 13
M. Doria, N. Klein, R. Lucito, R. Schneider (1995)
The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors.The EMBO Journal, 14
I. Qadri, H. Maguire, A. Siddiqui (1995)
Hepatitis B virus transactivator protein X interacts with the TATA-binding protein.Proceedings of the National Academy of Sciences of the United States of America, 92 4
G. Pugliese, M. Favero (1999)
Rising Incidence of Hepatocellular Carcinoma in the United StatesInfection Control & Hospital Epidemiology, 20
R. Florese, M. Nagano‐Fujii, Yasuhiro Iwanaga, R. Hidajat, H. Hotta (2002)
Inhibition of protein synthesis by the nonstructural proteins NS4A and NS4B of hepatitis C virus.Virus research, 90 1-2
H. Alter, P. Holland, R. Purcell (1975)
The emerging pattern of post-transfusion hepatitis.The American journal of the medical sciences, 270 2
A. Wasley, M. Alter (2000)
Epidemiology of Hepatitis C: Geographic Differences and Temporal TrendsSEMINARS IN LIVER DISEASE, Volume 20
Wang Wang, Gibson Gibson, Vermeulen Vermeulen (1995)
Abrogation of p53‐induced apoptosis by the hepatitis B virus X geneCancer Res, 55
Qadri Qadri, Iwahashi Iwahashi, Simon Simon (2002)
Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3Biochem Biophys Acta, 1592
F. Bortolotti, S. Faggion, P. Con (1998)
Natural history of chronic viral hepatitis in childhood.Acta gastro-enterologica Belgica, 61 2
Jingyu Diao, Robert Garces, Christopher Richardson, Christopher Richardson, Christopher Richardson (2001)
X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis.Cytokine & growth factor reviews, 12 2-3
S. Rowan, R. Ludwig, Y. Haupt, S. Bates, Xin Lu, M. Oren, K. Vousden (1996)
Specific loss of apoptotic but not cell‐cycle arrest function in a human tumor derived p53 mutant.The EMBO Journal, 15
C. Harris (1996)
Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies.Journal of the National Cancer Institute, 88 20
J. Bruix (1997)
Treatment of hepatocellular carcinomaHepatology, 25
Jacqueline Benn, R. Schneider (1995)
Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls.Proceedings of the National Academy of Sciences of the United States of America, 92 24
C. Caelles, A. Helmberg, M. Karin (1994)
p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genesNature, 370
O. Coqueret (2003)
New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?Trends in cell biology, 13 2
A. Cerny, F. Chisari (1999)
Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistenceHepatology, 30
H. Ueda, S. Ullrich, J. Gangemi, C. Kappel, L. Ngo, M. Feitelson, G. Jay (1995)
Functional inactivation but not structural mutation of p53 causes liver cancerNature Genetics, 9
J. Harper, G. Adami, N. Wei, K. Keyomarsi, S. Elledge (1993)
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 75
A. Ghosh, R. Steele, K. Meyer, R. Ray, Ratna Ray (1999)
Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth.The Journal of general virology, 80 ( Pt 5)
T. Kensler, P. Egner, Jin-bing Wang, Yuan‐rong Zhu, Bao-chu Zhang, G. Qian, S. Kuang, S. Gange, L. Jacobson, A. Muñoz, J. Groopman (2002)
Strategies for chemoprevention of liver cancer.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation, 11 Suppl 2
J. Kao, Ding‐Shinn Chen (2002)
Recent research progress in hepatocellular carcinoma.Journal of the Formosan Medical Association = Taiwan yi zhi, 101 4
M. Lee, E. Jung, H. Kwun, H. Jun, Dae-Yeul Yu, Yung-Hyun Choi, K. Jang (2002)
Hepatitis C virus core protein represses the p21 promoter through inhibition of a TGF-beta pathway.The Journal of general virology, 83 Pt 9
S. Rossol, J. Bartel (2006)
[Chronic hepatitis C virus infection].MMW Fortschritte der Medizin, 148 43
N. Méndez-Sánchez (2002)
[Epidemiology of hepatitis C].Revista de gastroenterologia de Mexico, 67 Suppl 2
M. Lee, E. Jung, H. Kwun, H. Jun, Dae-Yeul Yu, Yung-Hyun Choi, K. Jang (2002)
Hepatitis C virus core protein represses the p21 promoter through inhibition of a TGF-β pathwayJournal of General Virology, 83
G. Natoli, M. Avantaggiati, P. Chirillo, P. Puri, A. Ianni, C. Balsano, M. Levrero (1994)
Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX.Oncogene, 9 10
X. Wang, W. Vermeulen, J. Coursen, M. Gibson, Shawn Lupold, K. Forrester, G. Xu, L. Elmore, H. Yeh, J. Hoeijmakers, C. Harris (1996)
The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway.Genes & development, 10 10
Hubert Blum, ZHEN-SHENG Zhang, Eithan Galun, F. Weizsacker, Bill Garner, T. Liang, J. Wands (1992)
Hepatitis B virus X protein is not central to the viral life cycle in vitroJournal of Virology, 66
(1988)
Biological features of hepadna viruses
R. Beasley, C. Trepo, C. Stevens, W. Szmuness (1977)
The e antigen and vertical transmission of hepatitis B surface antigen.American journal of epidemiology, 105 2
Shi-Ming Lin, I. Sheen, R. Chien, C. Chu, Y. Liaw (1999)
Long‐term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infectionHepatology, 29
Yoshinori Murakami, Kenshi Hayashi, T. Sekiya (1991)
Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis.Cancer research, 51 13
W. Szmuness, M. Much, A. Prince, J. Hoofnagle, C. Cherubin, E. Harley, Gloria Block (1975)
On the role of sexual behavior in the spread of hepatitis B infection.Annals of internal medicine, 83 4
Takayuki Yamanaka, M. Uchida, T. Doi (2002)
Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein.Biochemical and biophysical research communications, 294 3
Jenny Heathcote, C. Cameron, D. Dane (1974)
Hepatitis-B antigen in saliva and semen.Lancet, 1 7847
M. Alter, H. Margolis, K. Krawczyński, F. Judson, A. Mares, W. Alexander, Pindiga Hu, Joan Miller, M. Gerber, R. Sampliner, Emory Meeks, M. Beach (1992)
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.The New England journal of medicine, 327 27
Teh-Hsiu Lee, S. Elledge, J. Butel (1995)
Hepatitis B virus X protein interacts with a probable cellular DNA repair proteinJournal of Virology, 69
H. Maguire, James Hoeffler, Aleem Siddiqui (1991)
HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactionsScience, 252
K. Ikeda, S. Saitoh, Yoshiyuki Suzuki, M. Kobayashi, A. Tsubota, M. Fukuda, I. Koida, Y. Arase, K. Chayama, N. Murashima, H. Kumada (1998)
Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virusCancer, 82
A. Takamizawa, C. Mori, I. Fuke, S. Manabe, S. Murakami, J. Fujita, E. Onishi, T. Andoh, I. Yoshida, Hiroto Okayama (1991)
Structure and organization of the hepatitis C virus genome isolated from human carriersJournal of Virology, 65
X. Wang, K. Forrester, H. Yeh, M. Feitelson, Jen-Ren Gu, C. Harris (1994)
Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3.Proceedings of the National Academy of Sciences of the United States of America, 91 6
L. Seeff (2002)
Natural history of chronic hepatitis CHepatology, 36
W. Caselmann (1996)
Trans-activation of cellular genes by hepatitis B virus proteins: a possible mechanism of hepatocarcinogenesis.Advances in virus research, 47
S. Thorgeirsson, J. Grisham (2002)
Molecular pathogenesis of human hepatocellular carcinomaNature Genetics, 31
Summary. Hepatocellular carcinoma (HCC) is the most important primary hepatic cancer, being a common cancer type worldwide. Many aetiological factors have been related with HCC development, such as cirrhosis, hepatitis viruses and alcohol. Chronic infection with hepatitis B (HBV) and C viruses (HCV) often results in cirrhosis and enhances the probability of developing HCC. The underlying mechanisms that lead to malignant transformation of infected cells, however, remain unclear. HBV is a DNA virus that integrates into the host genome, and this integration is believed, in part, to be carcinogenic. Besides, the virus encodes a 17 kDa protein, HBx, which is known to be a causative agent in the formation of HCC. On the contrary, HCV is a RNA virus that does not integrate into the host genome but likely induces HCC through host protein interactions or via the inflammatory response to the virus. Products encoded in the HCV genome interfere with and disturb intracellular signal transduction. Some HCV proteins, such as the core protein, NS3 and NS5A, have seen to have a regulatory effect on cellular promoters, to interact with a number of cellular proteins, and to be involved in programmed‐cell death modulation under certain conditions. The identification of these proteins functions in HCC development and the subsequent development of strategies to inhibit protein–protein interactions may be the first step towards reducing the chronicity and/or of the carcinogenicity of these two viruses.
Journal of Viral Hepatitis – Wiley
Published: Sep 1, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.